FDA recall, , Low risk
Meitheal Pharmaceuticals Vecuronium Bromide for Injection
Vecuronium Bromide for Injection lacks a warning or Rx legend on its label.
What happened
Meitheal Pharmaceuticals, Inc., of Chicago, Illinois, is voluntarily recalling Vecuronium Bromide for Injection because the label lacks a warning or Rx legend. The FDA has added the recall to its Enforcement Report as of October 29, 2026, and the agency classified it that same day.
The product was distributed nationwide in the United States. The recall began on October 8, 2026, and customers were notified by letter.
2 photos
What to do
The FDA notice gives no instructions for this recall. FDA's general advice for medicine recalls:
- Check the FDA or company notice for instructions specific to this product.
- Ask your pharmacist or doctor whether your lot is affected and what to do.
Is yours affected?
Match your product and all the details in one listed combination.
An NDC (National Drug Code) is usually printed on the drug's label.
Vecuronium Bromide for Injection
- Strength
- 10 mg
- NDC
- 71288-744-11
- Lot code
- T1P0213A
- T1P0313A
- T1P0412A
- T1P0413A
- T1P0512A
- T1P0513A
- Strength
- 20 mg
- NDC
- 71288-745-21
- Lot code
- T1P0113C
- T1P0612C
Recall details
- Posted by FDA
- Recall began
- Status
- Open
- Weekly archive
- Listed the week of Oct 26, 2026
- Sold in
US. Nationwide
- Recalled by
- Meitheal Pharmaceuticals, IncChicago, Illinois
- Hazard
- Labeling error
- Risk
Low risk
Taking it is unlikely to cause health problems.
FDA Class III recall · How risk is rated
- FDA event number
- 100110
- Recall numbers
- D-0108-2027 to D-0109-2027
- Recall type
- Voluntary: Firm initiated
- How the company first told customers
- Letter
All recalls from Meitheal Pharmaceuticals, Inc
Timeline
FDA's Enforcement Report is its public list of recalls; FDA posts a recall by adding it there.
Meitheal Pharmaceuticals began the recall
FDA posted the recall to its Enforcement Report and rated it Class III (low risk)
Added to Recall Canary
Summary updated



